Introduction
The diagnostic value of clinical tests and magnetic resonance (MR) imaging for the investigation of triangular fibrocartilaginous complex (TFCC) lesions is not clear due to a lack of ...clinical data.
Materials and methods
We retrospectively analyzed 908 patients who underwent clinical tests and arthroscopy for suspected TFCC lesions at our institution. Further, MR imaging findings concerning the TFCC were gathered. We correlated clinical tests and MR imaging findings with those obtained during arthroscopy, and we calculated sensitivity, specificity, as well as positive and negative predictive values.
Results
In the whole cohort, the positive predictive values of all clinical tests were low, ranging from 0.53 to 0.55. The ulna grinding test had the highest sensitivity, but lowest specificity. Sensitivity and specificity of the ulnar fovea sign and magnetic resonance imaging were similar, ranging from 0.73 to 0.76, and from 0.41 to 0.44, respectively. To some degree, the diagnostic value seemed to depend on the Palmer class of TFCC lesion.
Conclusions
According to this study, clinical tests and MR imaging findings are of very limited diagnostic value for the diagnosis of TFCC lesions.
VLA2001 is a highly-purified, inactivated whole-virus SARS-CoV-2 vaccine based on a dual-adjuvant system of Alum and CpG1018 for induction of a robust immune response. The vaccine was designed using ...a well-established technology platform and has received full marketing authorization in Europe. In a pivotal Phase 3 trial, VLA2001 demonstrated superior neutralizing antibody geometric mean titers (GMT) to the comparator, AstraZeneca's AZD1222, as well as non-inferior seroconversion rates two weeks after priming. The extension of the Phase 3 trial evaluated safety and immunogenicity of homologous and heterologous booster vaccinations of VLA2001.
This is a randomized observer-blind controlled, pivotal trial conducted in the UK in participants aged ≥18 years who were randomly assigned 2:1 to receive two doses of VLA2001 or AZD1222, 28 days apart. A booster with VLA2001 was administered to eligible participants at 7 to 8 months after priming. The primary safety outcome was the frequency and severity of any adverse event following the booster vaccination. The primary immunogenicity outcomes were the GMT and fold increase of neutralizing antibodies against SARS-CoV-2 two weeks after the booster vaccination. The study is registered under NCT04864561.
A booster dose of VLA2001 is well-tolerated in both AZD1222 and VLA2001 primed participants. High neutralizing antibody titers and fold- increases were generated two weeks following a booster of VLA2001. Cross- neutralizing serological responses against Delta and the Omicron BA.4/BA.5 variants of concern are elicited following a homologous or heterologous booster dose in VLA2001 or AZD1222 primed participants, respectively. Additionally, VLA2001 induced broad T-cell responses with antigen-specific IFN-gamma producing T-cells against the Spike, the Nucleocapsid and the Membrane protein.
Homologous and heterologous booster doses of VLA2001 demonstrated a favorable tolerability profile irrespective of priming and induced broadly reactive neutralizing antibodies against the ancestral virus and variants of concern, including the currently circulating BA.4/BA.5.
Viruses infect millions of people each year. Both endemic viruses circulating throughout the population as well as novel epidemic and pandemic viruses pose ongoing threats to global public health. ...Developing more effective tools to address viruses requires not only in‐depth knowledge of the virus itself but also of our immune system's response to infection. On June 29 to July 2, 2022, researchers met for the Keystone symposium “Viral Immunity: Basic Mechanisms and Therapeutic Applications.” This report presents concise summaries from several of the symposium presenters.
Viruses infect millions of people each year. Both endemic viruses circulating throughout the population as well as novel epidemic and pandemic viruses pose ongoing threats to global public health. Developing more effective tools to address viruses requires not only in‐depth knowledge of the virus itself but also of our immune system's response to infection. On June 29 to July 2, 2022, researchers met for the Keystone symposium “Viral Immunity: Basic Mechanisms and Therapeutic Applications.” The meeting was held jointly with the symposium “Respiratory Viruses: New Frontiers.”
Objective
Although in widespread clinical use, evidence of the diagnostic accuracy of radiographic parameters for the diagnosis of scapholunate ligament injuries is scarce. The objective of this ...study was to evaluate the scapholunate (SL) angle, radiolunate (RL) angle and SL gap as diagnostic parameters for these lesions.
Methods
Eight hundred forty nine patients, who underwent wrist arthroscopy at our institution because of wrist pain were included in a retrospective analysis. In all patients the SL angle, RL angle and SL gap were measured on preoperative radiographs. These parameters were correlated with the actual finding of the SL ligament during arthroscopy. Optimal test thresholds were calculated as well as sensitivity, specificity and the likelihood ratios of each parameter.
Results
All three parameters proved useful in statistical analysis. The optimal cut-off points for diagnosing lesions of the SL ligament were calculated as 62.5° for the SL angle, 12.5° for the RL angle and 2.5 mm for the SL gap. SL angles had the greatest specificity (0.93).
Conclusions
We were able to validate plain radiographs as a reliable tool in the work-up of patients with suspected SL ligament injuries. However, wrist arthroscopy remains the gold standard in diagnosing and treating these lesions.
Summary
Zoonotic transmission of Ebola virus (EBOV) to humans causes a severe haemorrhagic fever in afflicted individuals with high case‐fatality rates. Neither vaccines nor therapeutics are at ...present available to combat EBOV infection, making the virus a potential threat to public health. To devise antiviral strategies, it is important to understand which components of the immune system could be effective against EBOV infection. The interferon (IFN) system constitutes a key innate defence against viral infections and prevents development of lethal disease in mice infected with EBOV strains not adapted to this host. Recent research revealed that expression of the host cell IFN‐inducible transmembrane proteins 1–3 (IFITM1–3) and tetherin is induced by IFN and restricts EBOV infection, at least in cell culture model systems. IFITMs, tetherin and other effector molecules of the IFN system could thus pose a potent barrier against EBOV spread in humans. However, EBOV interferes with signalling events required for human cells to express these proteins. Here, we will review the strategies employed by EBOV to fight the IFN system, and we will discuss how IFITM proteins and tetherin inhibit EBOV infection.
DC-SIGN, a C-type lectin expressed on the surface of dendritic cells (DCs), efficiently binds and transmits HIVs and simian immunodeficiency viruses to susceptible cells in trans. A DC-SIGN ...homologue, termed DC-SIGNR, has recently been described. Herein we show that DC-SIGNR, like DC-SIGN, can bind to multiple strains of HIV-1, HIV-2, and simian immunodeficiency virus and transmit these viruses to both T cell lines and human peripheral blood mononuclear cells. Binding of virus to DC-SIGNR was dependent on carbohydrate recognition. Immunostaining with a DC-SIGNR-specific antiserum showed that DC-SIGNR was expressed on sinusoidal endothelial cells in the liver and on endothelial cells in lymph node sinuses and placental villi. The presence of this efficient virus attachment factor on multiple endothelial cell types indicates that DC-SIGNR could play a role in the vertical transmission of primate lentiviruses, in the enabling of HIV to traverse the capillary endothelium in some organs, and in the presentation of virus to CD4-positive cells in multiple locations including lymph nodes.
Ionic liquids in supercapacitors Brandt, A.; Pohlmann, S.; Varzi, A. ...
MRS bulletin,
07/2013, Letnik:
38, Številka:
7
Journal Article
Recenzirano
Supercapacitors are nowadays considered to be one of the most important electrochemical storage devices. These devices display high power and extraordinary cycle life, and they are currently used in ...an increasing number of applications. However, in order to further increase the applications of supercapacitors, an increase in their energy capacity appears to be necessary. Moreover, the development of safe and environmentally friendly supercapacitors is also required. In this article, we illustrate the contributions ionic liquids (ILs) might play in the development of high energy and safe supercapacitors. First, the use of ILs as electrolytes in supercapacitors is considered, and the advantages as well as challenges related to the use of this kind of electrolyte are analyzed. Next, the interaction between ILs and electrode materials is taken into account, with particular attention paid to inactive components of supercapacitor electrodes. The introduction of natural cellulose as a binder is used as an example of the contribution ILs might provide to the development of environmentally friendly supercapacitors.
PDF
